Controlled Substance Awareness Training

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Step Status
Educational Materials
Evaluation
Starts On: Tue, 2/19/19: 12:00 AM
Ends On: Thu, 2/18/21: 12:00 AM
Credits: 0.75
Description: Completion of this CME activity fulfills the state mandated Awareness Training for Controlled Substances. It fulfills all areas as required in the rule of Public Act 247 of 2017.
Educational Objectives: At the end of this activity, participant should be able to:
  1. Understand the risk and benefit associated with prescribing and administration of opioids and other controlled substances.
  2. Understand how to compliment use of controlled substances with integrated treatments.
  3. Demonstrate awareness of alternative treatments for pain management.
  4. Counsel patients on teh effects and risks associated with controlled substances.
  5. Explain the stigma of addiction (substance use disorder).
  6. Utilize the Michigan Automated Prescription System.
Target Audience: This activity is appropriate for Physicians and other health professionals in all fields of practice.
Accreditation Information:

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This CME activity was released in February 2019 with credit available through January 2022.

Additional Info: Presenter & Educational Planner:
Paul Hilliard, MD

Educational Co-Planners:
Katie Barwig, MS
Christopher Martin, MD
Eric Scott, PhD

Financial Disclosures:
There are no relevant financial relationships with ACCME-defined commercial interests to disclose for this activity.

Credits available:

AMA PRA Category 1:  0.75
Participation:  0.75